MedAvail Ranked in the Top 500 Fastest-Growing Companies in North America
November 17 2022 - 8:00AM
MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a
technology-enabled pharmacy company, today announced that it ranked
for the first time on the Deloitte Technology Fast 500™, an award
aimed at recognizing innovative technology companies that redefine
the cutting edge.
The award recognized MedAvail’s mission to transform the retail
pharmacy industry by offering turnkey in-clinic pharmacy services
through its proprietary robotic dispensing platform – its
MedCenter. Technology Fast 500 awardees are selected based on the
percentage revenue growth from 2018 to 2021. MedAvail reported
total revenue of $22.1 million in 2021, representing 374% growth
since 2018.
“We are incredibly honored to have been distinguished among the
top 500 fastest-growing innovative technology companies by an award
that demonstrates our strong growth over the last few years. We are
also excited to see our momentum continue in 2022, as we expand our
retail pharmacy footprint and broaden our technology pipeline,”
said Mark Doerr, chief executive officer of MedAvail. “We see a
significant opportunity ahead for MedAvail as our team continues
with strong execution across strategic initiatives and focus on
improving patient medication access and adherence with our
differentiated technology solution.”
About the 2022 Deloitte Technology Fast
500™
Now in its 28th year, the Deloitte Technology Fast 500 honors
the most innovative, fastest-growing public and private companies
all over North America. The awards program was created to recognize
the passion and dedication it takes to be a disruptor across
different industries, including the technology and life sciences
sectors. The rankings are compiled based on submitted applications
and public company database research, with winners selected based
on their percentage fiscal-year revenue growth over a three-year
period.
About MedAvailMedAvail Holdings, Inc. (NASDAQ:
MDVL) is a technology-enabled pharmacy organization, providing
turnkey in-clinic pharmacy services through its proprietary robotic
dispensing platform, the MedAvail MedCenter, and home delivery
operations, to Medicare clinics. MedAvail helps patients to
optimize drug adherence, resulting in better health outcomes. Learn
more at www.medavail.com.
Contacts:
Investor RelationsJi-Yon YiGilmartin
Groupir@medavail.comSOURCE MedAvail Holdings, Inc.
MedAvail (NASDAQ:MDVL)
Historical Stock Chart
From Jun 2024 to Jul 2024
MedAvail (NASDAQ:MDVL)
Historical Stock Chart
From Jul 2023 to Jul 2024